Zhao Y, OKeefe C, Hu J, Allan C, Cui W, Lei H
Sci Adv. 2024; 10(47):eadp1704.
PMID: 39576863
PMC: 11584010.
DOI: 10.1126/sciadv.adp1704.
Sacristan C, Youngblood B, Lu P, Bally A, Xu J, McGary K
Cell Rep. 2024; 43(8):114547.
PMID: 39083377
PMC: 11522508.
DOI: 10.1016/j.celrep.2024.114547.
Jeddi F, Faghfuri E, Mehranfar S, Soozangar N
Cancer Cell Int. 2024; 24(1):240.
PMID: 38982390
PMC: 11234524.
DOI: 10.1186/s12935-024-03405-2.
Lee H, Shin C, Chang Y, Yoon H, Park Y, Kim N
Gastric Cancer. 2024; 27(5):1031-1045.
PMID: 38970748
DOI: 10.1007/s10120-024-01532-3.
Wang X, Dong Y, Zhang H, Zhao Y, Miao T, Mohseni G
Genes Dis. 2023; 11(2):847-860.
PMID: 37692483
PMC: 10491876.
DOI: 10.1016/j.gendis.2023.02.038.
Depletion of the mA demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma.
Hu W, Klumper N, Schmidt D, Ritter M, Ellinger J, Hauser S
Am J Transl Res. 2023; 15(3):1744-1755.
PMID: 37056835
PMC: 10086911.
Eradication Can Reverse Rho GTPase Expression in Gastric Carcinogenesis.
Kim J, Kim S, Natsagdorj E, Chung H, Cho S
Gut Liver. 2023; 17(5):741-752.
PMID: 36718103
PMC: 10502497.
DOI: 10.5009/gnl220301.
Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review.
Ghadiri Moghaddam F, Farajnia S, Karbalaei-Mahdi M, Monir L
Mol Biol Rep. 2022; 49(10):10013-10022.
PMID: 35727475
DOI: 10.1007/s11033-022-07569-w.
IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Yang J, Wang J, Li H, Gao S, Fan Y, Wang K
Front Oncol. 2022; 12:746643.
PMID: 35359408
PMC: 8962649.
DOI: 10.3389/fonc.2022.746643.
The DNA methylome of cervical cells can predict the presence of ovarian cancer.
Barrett J, Jones A, Evans I, Reisel D, Herzog C, Chindera K
Nat Commun. 2022; 13(1):448.
PMID: 35105887
PMC: 8807742.
DOI: 10.1038/s41467-021-26615-y.
Aberrant DNA Methylation Maker for Predicting Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasms.
Shin C, Kim N, Yoon H, Choi Y, Park J, Park Y
Cancer Res Treat. 2022; 54(4):1157-1166.
PMID: 35038821
PMC: 9582476.
DOI: 10.4143/crt.2021.997.
DNA methylation profile in patients with indolent systemic mastocytosis.
Gorska A, Jablonska E, Reszka E, Niedoszytko M, Lange M, Gruchala-Niedoszytko M
Clin Transl Allergy. 2021; 11(9):e12074.
PMID: 34754417
PMC: 8561632.
DOI: 10.1002/clt2.12074.
Nanopore Technology and Its Applications in Gene Sequencing.
Lin B, Hui J, Mao H
Biosensors (Basel). 2021; 11(7).
PMID: 34208844
PMC: 8301755.
DOI: 10.3390/bios11070214.
Developmental plasticity allows outside-in immune responses by resident memory T cells.
Fonseca R, Beura L, Quarnstrom C, Ghoneim H, Fan Y, Zebley C
Nat Immunol. 2020; 21(4):412-421.
PMID: 32066954
PMC: 7096285.
DOI: 10.1038/s41590-020-0607-7.
Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer.
Wong E, Southey M, Terry M
Br J Cancer. 2020; 122(8):1133-1140.
PMID: 32066913
PMC: 7156506.
DOI: 10.1038/s41416-019-0720-2.
Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary.
Koder G, Olasz J, Tanyi J, George E, Toth L, Antal-Szalmas P
J Gastrointest Cancer. 2020; 51(3):1007-1015.
PMID: 31939059
PMC: 7399673.
DOI: 10.1007/s12029-020-00359-2.
Polymerase chain reaction - surface-enhanced Raman spectroscopy (PCR-SERS) method for gene methylation level detection in plasma.
Li X, Yang T, Li C, Song Y, Wang D, Jin L
Theranostics. 2020; 10(2):898-909.
PMID: 31903158
PMC: 6929977.
DOI: 10.7150/thno.30204.
Eradication Can Reverse the Methylation-Associated Regulation of in Gastric Carcinogenesis.
Choi J, Kim S, Yang H, Lim J, Cho N, Kim W
Gut Liver. 2019; 14(5):571-580.
PMID: 31887809
PMC: 7492500.
DOI: 10.5009/gnl19299.
Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies.
Nunes S, Diniz F, Moreira-Barbosa C, Constancio V, Silva A, Oliveira J
J Clin Med. 2019; 8(9).
PMID: 31546933
PMC: 6780554.
DOI: 10.3390/jcm8091500.
Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
Wasenang W, Chaiyarit P, Proungvitaya S, Limpaiboon T
Clin Epigenetics. 2019; 11(1):39.
PMID: 30832707
PMC: 6399934.
DOI: 10.1186/s13148-019-0634-0.